4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-18-000035
Sr. VP & Chief Medical Officer sold 4,155 shares at an average $95.32 ($396,036)
- Sr. VP & Chief Medical Officer acquired 2,955 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Adda Nathalie · Sr. VP & Chief Medical Officer
Table I: Non-derivative
6 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2018-09-20 | Exercise or conversion : show line 1 in the form | +2,955 | $43.46 | $128,424 | 4,155 | D |
| 2018-09-20 | Sale : show line 2 in the form | −500 | $93.02 | $46,509 | 3,655 | D |
| 2018-09-20 | Sale : show line 3 in the form | −453 | $93.90 | $42,535 | 3,202 | D |
| 2018-09-20 | Sale : show line 4 in the form | −1,229 | $94.75 | $116,451 | 1,973 | D |
| 2018-09-20 | Sale : show line 5 in the form | −602 | $95.84 | $57,699 | 1,371 | D |
| 2018-09-20 | Sale : show line 6 in the form | −1,371 | $96.89 | $132,842 | 0 | D |
| Open-market sales · 4,155 sh · avg $95.32 · $396,036 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2018-09-20 | Exercise or conversion : show line 7 in the form Stock Option (Right to Buy) | −2,955 | $43.46 | 2025-06-29 | 2,955 | 72,270 | D |
Loading xslF345X03/edgar.xml…